Platelet Aggregation Inhibitors Market Research Report Forecast to 2025
Platelet are blood cells, which make up small volume of the blood and prevents bleeding. Platelet-aggregation inhibiting drugs prevent blood clot inside of the body as during atherosclerosis. Platelet aggregation inhibitors are antiplatelet drugs prescribed during coronary artery diseases, chest pain, stroke, periphery artery disease (PAD), etc. It is also used during heart bypass surgery, atrial fibrillation, after angioplasty and stent placement. Platelet aggregation is the biological process, mediated by PAF (platelet activation factor). Platelet aggregation inhibitors are used during...
View full press release